Thiotepa
Back to searchMolecule Structure
Scientific Name
Thiotepa
Description of the Drug
Thiotepa is an alkylating agent used to prevent graft rejection in stem cell transplantation and to treat a variety of malignancies including certain types of adenocarcinoma and superficial bladder carcinomas.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04572
http://www.drugbank.ca/drugs/DB04572
Brand Name(s)
Tepadina, Thioplex, Thiotepa
Company Owner(s)
Msn Laboratories Private Ltd, Fresenius Kabi Usa Llc, West-Ward Pharmaceuticals International Ltd, Gland Pharma Ltd, Teva Parenteral Medicines Inc, Beloteca Inc, Dr Reddys Laboratories Ltd, Sti Pharma Llc, Immunex Corp, Jiangsu Hengrui Pharmaceuticals Co Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4760 | |
Human Metabolome Database | HMDB0015576 | |
DrugBank | DB04572 | |
PubChem: Thomson Pharma | 15322228 | |
PubChem | 5453 | |
Mcule | MCULE-5478761622 | |
LINCS | LSM-2194 | |
Nikkaji | J2.307H | |
BindingDB | 50418086 | |
EPA CompTox Dashboard | DTXSID0021339 | |
DrugCentral | 2638 | |
ChemicalBook | CB0458870 | |
Guide to Pharmacology | 7622 | |
rxnorm | TEPADINA | THIOTEPA |
KEGG Ligand | C07641 | |
ChEBI | 9570 | |
ZINC | ZINC000001530867 |